Health care technology in the United States

Sean R. Tunis, Hellen Gelband

Research output: Contribution to journalArticle

Abstract

The US health care system reflects the free market of the US economy-there is no fixed budget and no limit on expenditures in the loosely structured matrix of largely private-sector health industry components. Mainly because of the inaccessibility of adequate health care for a large segment of the population, and because the enormous cost of care threatens financial ruin for many more people, the first major reform of the system was debated in Congress for most of 1994, though, in the end, no leglislation was passed. One focus of the debate on spending has been the problem of excessive use of expensive medical technology and the need for some control, which, by and large, is lacking in the existing system. Health care technology assessment itself is a thriving industry in the United States, used by government, insurers, medical societies, hospitals, and other groups for their own purposes. At the national policy level, few opportunities for technology assessment to affect the health care industry exist, so most effort is directed at trying to affect medical practice at the level of the individual hospital and practitioner. The discernible effect of technology assessment has been minimal.

Original languageEnglish (US)
Pages (from-to)335-396
Number of pages62
JournalHealth Policy
Volume30
Issue number1-3
DOIs
StatePublished - 1994
Externally publishedYes

Fingerprint

Biomedical Technology Assessment
Biomedical Technology
Industry
Delivery of Health Care
State Government
Insurance Carriers
Health Care Sector
Private Sector
Medical Societies
Budgets
Health Expenditures
Technology
Costs and Cost Analysis
Health
Population

Keywords

  • Health care technology
  • Medical devices
  • Pharmaceuticals
  • Technology assessment
  • United States

ASJC Scopus subject areas

  • Health Policy
  • Public Health, Environmental and Occupational Health

Cite this

Health care technology in the United States. / Tunis, Sean R.; Gelband, Hellen.

In: Health Policy, Vol. 30, No. 1-3, 1994, p. 335-396.

Research output: Contribution to journalArticle

Tunis, Sean R. ; Gelband, Hellen. / Health care technology in the United States. In: Health Policy. 1994 ; Vol. 30, No. 1-3. pp. 335-396.
@article{bfae402420074ac49e6cf26fb5ac3c69,
title = "Health care technology in the United States",
abstract = "The US health care system reflects the free market of the US economy-there is no fixed budget and no limit on expenditures in the loosely structured matrix of largely private-sector health industry components. Mainly because of the inaccessibility of adequate health care for a large segment of the population, and because the enormous cost of care threatens financial ruin for many more people, the first major reform of the system was debated in Congress for most of 1994, though, in the end, no leglislation was passed. One focus of the debate on spending has been the problem of excessive use of expensive medical technology and the need for some control, which, by and large, is lacking in the existing system. Health care technology assessment itself is a thriving industry in the United States, used by government, insurers, medical societies, hospitals, and other groups for their own purposes. At the national policy level, few opportunities for technology assessment to affect the health care industry exist, so most effort is directed at trying to affect medical practice at the level of the individual hospital and practitioner. The discernible effect of technology assessment has been minimal.",
keywords = "Health care technology, Medical devices, Pharmaceuticals, Technology assessment, United States",
author = "Tunis, {Sean R.} and Hellen Gelband",
year = "1994",
doi = "10.1016/0168-8510(94)00692-8",
language = "English (US)",
volume = "30",
pages = "335--396",
journal = "Health Policy",
issn = "0168-8510",
publisher = "Elsevier Ireland Ltd",
number = "1-3",

}

TY - JOUR

T1 - Health care technology in the United States

AU - Tunis, Sean R.

AU - Gelband, Hellen

PY - 1994

Y1 - 1994

N2 - The US health care system reflects the free market of the US economy-there is no fixed budget and no limit on expenditures in the loosely structured matrix of largely private-sector health industry components. Mainly because of the inaccessibility of adequate health care for a large segment of the population, and because the enormous cost of care threatens financial ruin for many more people, the first major reform of the system was debated in Congress for most of 1994, though, in the end, no leglislation was passed. One focus of the debate on spending has been the problem of excessive use of expensive medical technology and the need for some control, which, by and large, is lacking in the existing system. Health care technology assessment itself is a thriving industry in the United States, used by government, insurers, medical societies, hospitals, and other groups for their own purposes. At the national policy level, few opportunities for technology assessment to affect the health care industry exist, so most effort is directed at trying to affect medical practice at the level of the individual hospital and practitioner. The discernible effect of technology assessment has been minimal.

AB - The US health care system reflects the free market of the US economy-there is no fixed budget and no limit on expenditures in the loosely structured matrix of largely private-sector health industry components. Mainly because of the inaccessibility of adequate health care for a large segment of the population, and because the enormous cost of care threatens financial ruin for many more people, the first major reform of the system was debated in Congress for most of 1994, though, in the end, no leglislation was passed. One focus of the debate on spending has been the problem of excessive use of expensive medical technology and the need for some control, which, by and large, is lacking in the existing system. Health care technology assessment itself is a thriving industry in the United States, used by government, insurers, medical societies, hospitals, and other groups for their own purposes. At the national policy level, few opportunities for technology assessment to affect the health care industry exist, so most effort is directed at trying to affect medical practice at the level of the individual hospital and practitioner. The discernible effect of technology assessment has been minimal.

KW - Health care technology

KW - Medical devices

KW - Pharmaceuticals

KW - Technology assessment

KW - United States

UR - http://www.scopus.com/inward/record.url?scp=0028590210&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028590210&partnerID=8YFLogxK

U2 - 10.1016/0168-8510(94)00692-8

DO - 10.1016/0168-8510(94)00692-8

M3 - Article

VL - 30

SP - 335

EP - 396

JO - Health Policy

JF - Health Policy

SN - 0168-8510

IS - 1-3

ER -